Pfizer Inc. (PFE) — Stock Valuation & Research

Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective…

PFE key statistics

Price$27.58
Market cap$157.16B
SectorHealthcare
IndustryDrug Manufacturers - General
ExchangeNYSE
52-week range23.58-29.21
Dividend (TTM)$1.72 per share
Beta0.3

Explore PFE's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.